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Abstract
This editorial presents Retrovirology's choice for the best basic science "retrovirus paper of the
year 2005".
Chronic HIV-1 infection is characterized by a steady but
generally slow loss of CD4+ T cells. A central puzzle of
HIV-1 research in the early 90's has been how the virus
could cause AIDS, when it infects a trivial number of T
cells. It took until 1995 before it was realized that massive
virus replication occurs during chronic infection [1]. A
model was proposed in which HIV-1 kills healthy cells
slightly faster than the human body is able to replenish.
David Ho, in a paraphrase of former US president Bill
Clinton, said "It's the virus, stupid" to underscore the pri-
mary role of the virus in the pathogenesis of AIDS. This
finding sets the stage for the implementation of viral load
tests in routine diagnostics. The new concept also pro-
vided the rationale for attempts to block the furiously rep-
licating virus with antivirals, instead of resolving the
disease by modulating the immune system.
Nevertheless, the frequency of infected peripheral CD4+ T
cells in the chronic phase of HIV-1 infection is too low
(0.01 – 1%) to account for the ongoing depletion of these
cells by viral infection. In addition, the mechanism for the
massive and rapid loss during the acute phase of infection
remains unknown. Recent work with HIV-1 and SIV in the
macaque model demonstrated that acute infection is
accompanied by a dramatic and selective loss of memory
CD4+ T cells predominantly from the mucosal surfaces,
but the mechanism underlying this depletion was not
clarified. Two 2005 papers in Nature clearly repeated the
old message "It's the virus, stupid – part 2". I find that two
of the best basic science retrovirus papers of 2005 are the
works from Joseph Mattapallil and colleagues and Ging-
sheng Li and colleagues describing that HIV-1 infects and
kills the memory CD4+T cells, a T-cell subset responsible
for remembering previous infections [2], [3]. This initial
assault may determine the outcome of the lengthy battle
between SIV-HIV and its host.
Mattapallil et al. used a technique that can detect a single
copy of SIV DNA to show that 30–60% of all memory
CD4+ T cells were infected within 10 days of viral chal-
lenge. Most of these cells in the infected rhesus macaque
had disappeared 4 days later. There is an exclusive loss of
memory CD4+T cells not only from gut-associated
mucosal tissues, but also from organized lymph nodes
and peripheral blood. Li et al. characterized the activation
status of the SIV-producing cells in tissue sections, which
turn out to be predominantly resting lymphocytes. This
result may be surprising because this virus is known to
replicate more efficiently in activated cells, but mucosal
lymphocytes are probably better described as "recently
activated". Mattapallil suggests that the high rate of infec-
tion of these cells is a sufficient mechanism to account for
their loss during acute infection; no bystander mecha-
nisms need to be invoked. But Li suggests that indirect
mechanisms also contribute to T-cell death in acute infec-
tion. Recent studies have provided compelling evidence
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that the rapid and profound memory T cell depletion is
not a peculiarity of the SIV-macaque model, but is also
seen in the gut of acutely infected patients. Much remains
to be learned on how the substantial depletion of memory
CD4+ T cells during acute infection influences the gradual
depletion of CD4+ T cells during the chronic phase, and
how the removal of CCR5-positive memory cells relates to
the coreceptor switch towards CXCR4 that occurs in some
patients.
The two papers clearly demonstrate that our understand-
ing of the pathogenesis of AIDS has been biased by reli-
ance on examination of peripheral blood, which may
provide a limited and perhaps even misleading view. The
papers also have implications for antiretroviral treatment
and the development of vaccines. For instance, mucosal
immunity will be essential for designing an effective AIDS
vaccine. Early intervention drug therapy and vaccines
should ideally prevent the massive destruction of the
CD4+memory T cell compartment. Countermeasures
should be developed to attack the virus at or shortly after
transmission. The fight with antivirals or microbicides
should be targeted in the cervico-vaginal tissues, the pre-
dominant portal of viral entry in the HIV-1 pandemic. It
seems particularly important that vaccines should block
HIV-1 before the initial burst of viral replication in
mucosal lymphocytes. The best way to prevent this is by a
vaccine that induces potent neutralizing antibodies, but
that is easier said than done.
The new insights may also be relevant for studies that
focus on biological differences between the different HIV-
1 subtypes. A major determinant of subtype-specific dif-
ferences in host cell tropism and possibly pathogenesis is
encoded by the long terminal repeat (LTR) promoter of
HIV-1 [4]. Mireille Centlivre and colleagues inserted the
HIV-1 subtype LTRs in SIV and followed viral dissemina-
tion in macaque body compartments [5]. In direct virus
competition experiments, subtype C replicated preferen-
tially in the gut-associated lymphoid tissue and subtype B
was found predominantly in peripheral blood mononu-
clear cells during acute infection. The different chemok-
ine/interleukin environments are likely to differentially
influence the subtype LTR promoters that encode distinct
transcription factor binding sites. For instance, the gut-
associated lymphoid tissue is an IL-7 rich environment,
which specifically activates subtype C replication through
enhancement of LTR transcription [6]. Such differences in
the pathogenesis of acute HIV-SIV infection may translate
into differential disease progression.
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